Bausch Health Companies (BHC) Other Working Capital Changes (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Other Working Capital Changes came in at $27.0 million in Q1 2026, down 41.3% year-on-year from $46.0 million in Q1 2025, and up 184.38% quarter-over-quarter from -$32.0 million in Q4 2025.
Bausch Health Companies (BHC) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Other Working Capital Changes across 18 years of filings, most recently posting $27.0 million for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $27.0 million, down 41.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$22.0 million (down 164.71% YoY), and the FY2025 annual result was -$3.0 million, up 97.74% from the prior year.
- Other Working Capital Changes came in at $27.0 million for Q1 2026 at Bausch Health Companies, up from -$32.0 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $148.0 million in Q4 2023 to a low of -$121.0 million in Q1 2024.
- The 5-year median for Other Working Capital Changes is $15.0 million (2022), against an average of $10.6 million.
- Across the five-year window, Other Working Capital Changes soared 335.29% in 2023 and sank 700.0% in 2025, its largest moves.
- Bausch Health Companies' Other Working Capital Changes stood at $34.0 million in 2022, then soared by 335.29% to $148.0 million in 2023, then plunged by 108.78% to -$13.0 million in 2024, then plunged by 146.15% to -$32.0 million in 2025, then soared by 184.38% to $27.0 million in 2026.
- The last three Other Working Capital Changes figures came in at $27.0 million (Q1 2026), -$32.0 million (Q4 2025), and -$5.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.00 Mn |
| Mar 31, 2026 | 27.00 Mn |
| Dec 31, 2025 | -32.00 Mn |
| Dec 31, 2025 | -32.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -12.00 Mn |
| Jun 30, 2025 | -12.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | -13.00 Mn |
| Dec 31, 2024 | -13.00 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | -121.00 Mn |
| Mar 31, 2024 | -121.00 Mn |
| Dec 31, 2023 | 148.00 Mn |
| Dec 31, 2023 | 148.00 Mn |